{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:19:55Z","timestamp":1793229595720,"version":"4.5.0"},"reference-count":209,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.biomaterials.2005.11.031","type":"journal-article","created":{"date-parts":[[2005,12,7]],"date-time":"2005-12-07T08:36:55Z","timestamp":1133944615000},"page":"2450-2467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":440,"title":["Drug\/device combinations for local drug therapies and infection prophylaxis"],"prefix":"10.1016","volume":"27","author":[{"given":"Peng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Grainger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib1","article-title":"A one-two punch: drug\/medical device combination products are taking healthcare in a new direction. Is the pharmaceutical industry prepared?","volume":"4","author":"Dubin","year":"2004","journal-title":"Drug Deliv Technol"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib2","unstructured":"United States Food and Drug Administration; 21 CFR ?3.2(e); European Commission DG Enterprise, Directorate G, Unit 4, MEDDEV 2.1\/3 rev 2 (Council Directive 90\/385\/EEC, 65\/65\/EEC and 93\/42\/EEC), see http:\/\/europa.eu.int\/comm\/enterprise\/medical_devices\/meddev\/2_1_3____07-2001.pdf"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib3","series-title":"Pharmaceutical dosage forms and drug delivery systems","author":"Ansel","year":"1995"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/jbm.10406","article-title":"In vivo release of vancomycin from biodegradable beads","volume":"63","author":"Liu","year":"2002","journal-title":"J Biomed Mater Res"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib5","first-page":"436","article-title":"Antibiotic resistance. Nosocomial gram-negative infection","volume":"46","author":"Gransden","year":"1997","journal-title":"J Med Microbiol"},{"issue":"9","key":"10.1016\/j.biomaterials.2005.11.031_bib6","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.2042-7158.1994.tb03890.x","article-title":"Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties","volume":"46","author":"Zhang","year":"1994","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01569817","article-title":"Biofilms in device-related infections","volume":"15","author":"Khardori","year":"1995","journal-title":"J Ind Microbiol"},{"issue":"3\u20134","key":"10.1016\/j.biomaterials.2005.11.031_bib8","first-page":"205","article-title":"Infections from biomaterials and implants: a race for the surface","volume":"14","author":"Gristina","year":"1988","journal-title":"Med Prog Technol"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev.micro.56.012302.160705","article-title":"Biofilms as complex differentiated communities","volume":"56","author":"Stoodley","year":"2002","journal-title":"Annu Rev Microbiol"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/jac\/42.5.569","article-title":"Quorum sensing: a novel target for anti-infective therapy","volume":"42","author":"Finch","year":"1998","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.copbio.2004.08.013","article-title":"Quorum sensing and bacterial cross-talk in biotechnology","volume":"15","author":"March","year":"2004","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K","article-title":"Bacterial adhesion to orthopedic implant polymers","volume":"30","author":"Barton","year":"1996","journal-title":"J Biomed Mater Res"},{"issue":"11","key":"10.1016\/j.biomaterials.2005.11.031_bib13","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/375061","article-title":"The use of economic modeling to determine the hospital costs associated with nosocomial infections","volume":"36","author":"Roberts","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1067\/mic.2002.121099","article-title":"A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990\u20132000","volume":"30","author":"Stone","year":"2002","journal-title":"Am J Infect Control"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.aje.a113988","article-title":"The nationwide nosocomial infection rate. A new need for vital statistics","volume":"121","author":"Haley","year":"1985","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1046\/j.1469-0691.2002.00418.x","article-title":"Pathogenesis of catheter-related infections: lessons for new designs","volume":"8","author":"Pascual","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(78)90500-7","article-title":"Transluminal dilatation of coronary-artery stenosis","volume":"1","author":"Gruntzig","year":"1978","journal-title":"Lancet"},{"issue":"9353","key":"10.1016\/j.biomaterials.2005.11.031_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0140-6736(03)12275-1","article-title":"Drug-eluting stents in vascular intervention","volume":"361","author":"Fattori","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.biomaterials.2005.11.031_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators","volume":"331","author":"Fischman","year":"1994","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.biomaterials.2005.11.031_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group","volume":"331","author":"Serruys","year":"1994","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.biomaterials.2005.11.031_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4230","article-title":"Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review","volume":"4","author":"Meads","year":"2000","journal-title":"Health Technol Assess"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1050-1738(03)00038-0","article-title":"Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents","volume":"13","author":"Indolfi","year":"2003","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/euhj.1998.1150","article-title":"A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty: final results of the fluvastatin angiographic restenosis (FLARE) trial","volume":"20","author":"Serruys","year":"1999","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.biomaterials.2005.11.031_bib24","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1053\/euhj.2001.2627","article-title":"A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasound","volume":"22","author":"Serruys","year":"2001","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.biomaterials.2005.11.031_bib25","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.CIR.0000028335.31300.DA","article-title":"Results of prevention of restenosis with tranilast and its outcomes (PRESTO) trial","volume":"106","author":"Holmes","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.biomaterials.2005.11.031_bib26","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1211\/0022357044797","article-title":"Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives","volume":"56","author":"Birkenhauer","year":"2004","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"10.1016\/j.biomaterials.2005.11.031_bib27","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/sj.bjc.6602162","article-title":"Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer","volume":"91","author":"Chan","year":"2004","journal-title":"Br J Cancer"},{"issue":"9306","key":"10.1016\/j.biomaterials.2005.11.031_bib28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(02)07751-6","article-title":"Overcoming restenosis with sirolimus: from alphabet soup to clinical reality","volume":"359","author":"Poon","year":"2002","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.biomaterials.2005.11.031_bib29","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.biomaterials.2005.11.031_bib30","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"issue":"9390","key":"10.1016\/j.biomaterials.2005.11.031_bib31","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(03)14462-5","article-title":"Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)","volume":"362","author":"Schofer","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/01.CIR.0000109138.84579.FA","article-title":"Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the \u201creal world\u201d: the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry","volume":"109","author":"Lemos","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2174\/1381612043453289","article-title":"Local drug delivery using coated stents: new developments and future perspectives","volume":"10","author":"Tanabe","year":"2004","journal-title":"Curr Pharm Design"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib34","first-page":"417","article-title":"Drug-eluting stent trial","volume":"15","author":"Yamaguchi","year":"2004","journal-title":"Cardiac Practice"},{"issue":"7","key":"10.1016\/j.biomaterials.2005.11.031_bib35","first-page":"1373","article-title":"Preclinical restenosis models and drug-eluting stents: still important, still much to learn","volume":"44","author":"Schwartz","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib36","first-page":"348","article-title":"Endoluminal local delivery of PCNA\/cdc2 antisense oligonucleotides by porous balloon catheter does not affect neointima formation or vessel size in the pig coronary artery model of postangioplasty restenosis","volume":"41","author":"Robinson","year":"1997","journal-title":"Cathet Cardiovasc Diagn"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib38","unstructured":"Morice M-C. REALITY trial data. American College of Cardiology annual meeting 2005."},{"issue":"22","key":"10.1016\/j.biomaterials.2005.11.031_bib39","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000103666.25660.77","article-title":"Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis","volume":"108","author":"Degertekin","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1163\/156856203321478838","article-title":"Bioresorbable polymeric stents: current status and future promise","volume":"14","author":"Eberhart","year":"2003","journal-title":"J Biomater Sci Polym Ed"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-0037-1614629","article-title":"Antithrombogenic coating of stents using a biodegradable drug delivery technology","volume":"82","author":"Herrmann","year":"1999","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000051067","article-title":"Biodegradation of the copolymeric polylactide stent: long-term follow-up in a rabbit aorta model","volume":"38","author":"Hietala","year":"2001","journal-title":"J Vasc Res"},{"issue":"Suppl. 5","key":"10.1016\/j.biomaterials.2005.11.031_bib43","first-page":"S10","article-title":"Drug-eluting stents: role of stent design, delivery vehicle, and drug selection","volume":"3","author":"Rodgers Campbell","year":"2002","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14628840304614","article-title":"Impact of transport and drug properties on the local pharmacology of drug-eluting stents","volume":"5","author":"Hwang","year":"2003","journal-title":"Int J Cardiovasc Interven"},{"issue":"7","key":"10.1016\/j.biomaterials.2005.11.031_bib45","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/01.RES.0000016672.26000.9E","article-title":"Arterial ultrastructure influences transport of locally delivered drugs","volume":"90","author":"Hwang","year":"2002","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib46","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.CIR.0000050367.65079.71","article-title":"Local drug delivery via a coronary stent with programmable release pharmacokinetics","volume":"107","author":"Finkelstein","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib47","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11883-005-0047-8","article-title":"Evidence-based management of peripheral vascular disease","volume":"7","author":"Shammas","year":"2005","journal-title":"Curr Atheroscler Rep"},{"issue":"Suppl. 7A","key":"10.1016\/j.biomaterials.2005.11.031_bib48","first-page":"7H","article-title":"Experimental feasibility and efficacy of a novel modular segmented stent with in-situ programmable length and drug elution from a biodegradable polymer coating","volume":"96","author":"Carter","year":"2005","journal-title":"Am J Cardiol"},{"issue":"203","key":"10.1016\/j.biomaterials.2005.11.031_bib49","first-page":"1","article-title":"Xtent debuts customizable stents to positive reviews","volume":"9","author":"Lorenzo","year":"2005","journal-title":"Med Dev Daily"},{"issue":"8","key":"10.1016\/j.biomaterials.2005.11.031_bib50","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/s-2005-870131","article-title":"Mechanisms of biliary stent clogging: confocal laser scanning and scanning electron microscopy","volume":"37","author":"van Berkel","year":"2005","journal-title":"Endoscopy"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib51","first-page":"187","article-title":"Central venous catheter related infections: the role of antimicrobial catheters","volume":"3","author":"Chatzinikolaou","year":"2003","journal-title":"Mol Cell Biol Crit Care Med"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0924-8579(00)00234-X","article-title":"Intravenous access: related problems in oncology","volume":"16","author":"Viot","year":"2000","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.biomaterials.2005.11.031_bib53","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1345\/aph.10416","article-title":"Antimicrobial-coated\/bonded and -impregnated intravascular catheters","volume":"35","author":"Pai","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"12","key":"10.1016\/j.biomaterials.2005.11.031_bib54","first-page":"774","article-title":"Studies of a graphite\u2013benzalkonium\u2013oxacillin surface","volume":"45","author":"Jagpal","year":"1979","journal-title":"Am Surg"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00000658-198202000-00008","article-title":"The role of antibiotic bonding in the prevention of vascular prosthetic infections","volume":"195","author":"Greco","year":"1982","journal-title":"Ann Surg"},{"issue":"18","key":"10.1016\/j.biomaterials.2005.11.031_bib56","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1001\/jama.1991.03460180070035","article-title":"Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial","volume":"265","author":"Kamal","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib57","first-page":"149","article-title":"Anti-infective coatings reduce device-related infections","author":"Zhang","year":"2000","journal-title":"Antimicrob\/Anti-infect Mater"},{"issue":"5B","key":"10.1016\/j.biomaterials.2005.11.031_bib58","first-page":"3629","article-title":"Anti-infective catheters: novel strategies to prevent nosocomial infections in oncology","volume":"18","author":"Schierholz","year":"1998","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib59","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/infdis\/173.2.418","article-title":"The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin","volume":"173","author":"Raad","year":"1996","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199901073400101","article-title":"A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group","volume":"340","author":"Darouiche","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib61","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jama.281.3.261","article-title":"Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis","volume":"281","author":"Veenstra","year":"1999","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib62","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/00003246-199906000-00034","article-title":"The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters","volume":"27","author":"Marik","year":"1999","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib63","doi-asserted-by":"crossref","first-page":"267","DOI":"10.7326\/0003-4819-127-4-199708150-00002","article-title":"Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial","volume":"127","author":"Raad","year":"1997","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00003246-199802000-00015","article-title":"Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin","volume":"26","author":"Raad","year":"1998","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.biomaterials.2005.11.031_bib65","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archinte.162.8.871","article-title":"Intravascular catheter-related infections new horizons and recent advances","volume":"162","author":"Raad","year":"2002","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-127-4-199708150-00001","article-title":"Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial","volume":"127","author":"Maki","year":"1997","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib67","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jac\/37.2.315","article-title":"Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters","volume":"37","author":"Bach","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib68","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00003643-199707000-00014","article-title":"Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients","volume":"14","author":"George","year":"1997","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib69","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archinte.158.1.81","article-title":"Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia","volume":"158","author":"Heard","year":"1998","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib70","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/0310057X9702500607","article-title":"Infection in central lines: antiseptic-impregnated vs standard non-impregnated catheters","volume":"25","author":"Loo","year":"1997","journal-title":"Anaesth Intensive Care"},{"issue":"12","key":"10.1016\/j.biomaterials.2005.11.031_bib71","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/archsurg.1997.01430360094017","article-title":"A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections","volume":"132","author":"Tennenberg","year":"1997","journal-title":"Arch Surg"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib72","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/0310057X9602400305","article-title":"Central venous catheters revisited\u2014infection rates and an assessment of the new Fibrin Analysing System brush","volume":"24","author":"van Heerden","year":"1996","journal-title":"Anaesth Intensive Care"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib73","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0195-6701(97)90184-5","article-title":"Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial","volume":"37","author":"Logghe","year":"1997","journal-title":"J Hosp Infect"},{"issue":"9","key":"10.1016\/j.biomaterials.2005.11.031_bib74","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archsurg.1996.01430210084018","article-title":"No difference in catheter sepsis between standard and antiseptic central venous catheters. A prospective randomized trial","volume":"131","author":"Pemberton","year":"1996","journal-title":"Arch Surg"},{"issue":"8","key":"10.1016\/j.biomaterials.2005.11.031_bib75","first-page":"641","article-title":"Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis","volume":"62","author":"Ciresi","year":"1996","journal-title":"Am Surg"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00365549609027157","article-title":"High incidence of line-related infection and mechanical failure of an antiseptic impregnated central venous catheter in highly immunocompromised patients","volume":"28","author":"Ellis","year":"1996","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib77","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jac\/dkg361","article-title":"Comparison of microbial adherence to antiseptic and antibiotic central venous catheters using a novel agar subcutaneous infection model","volume":"52","author":"Gaonkar","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib78","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10096-002-0719-z","article-title":"In vitro evaluation of the antibacterial activity of three different central venous catheters against Gram-positive bacteria","volume":"21","author":"Yorganci","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/46.1.45","article-title":"The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity","volume":"46","author":"Schierholz","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib80","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/jac\/dkh483","article-title":"Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial","volume":"54","author":"Yuecel","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.biomaterials.2005.11.031_bib81","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.addr.2005.04.001","article-title":"Antibiotic resistance\u2014the problem intensifies","volume":"57","author":"Levy","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib82","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/scientificamerican0701-74","article-title":"Battling biofilms","volume":"285","author":"Costerton","year":"2001","journal-title":"Sci Am"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib83","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0025-6196(11)64196-7","article-title":"Clinical aspects of antimicrobial resistance","volume":"75","author":"Virk","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib84","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/47.5.589","article-title":"In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices","volume":"47","author":"Tambe","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib85","first-page":"267","article-title":"Biomaterials used for catheters","author":"Trooskin","year":"1994","journal-title":"Implant Biol"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib86","series-title":"Biocompatible polymers, metals, and composites","year":"1983"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib87","first-page":"89","article-title":"Clinical evaluation of elastomeric hydrogel peripheral catheters during home infusion therapy","volume":"13","author":"Crocker","year":"1990","journal-title":"J Intraven Nurs"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2005.11.031_bib88","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2004.05.017","article-title":"Antimicrobial activity of polyurethanes coated with antibiotics: a new approach to the realization of medical devices exempt from microbial colonization","volume":"280","author":"Piozzi","year":"2004","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib89","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/514518","article-title":"Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections","volume":"25","author":"Raad","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib90","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-127-4-199708150-00009","article-title":"Reducing the risk for catheter-related infections: a new strategy","volume":"127","author":"Pearson","year":"1997","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.biomaterials.2005.11.031_bib91","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1086\/383470","article-title":"Are antimicrobial-impregnated catheters effective? Don\u2019t throw out the baby with the bathwater","volume":"38","author":"Crnich","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.biomaterials.2005.11.031_bib92","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1086\/426086","article-title":"Are antimicrobial-impregnated catheters effective? Replace the water and grab your washcloth, because we have a baby to wash","volume":"39","author":"McConnell","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib93","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0002-9343(81)90561-1","article-title":"Nosocomial infections in US hospitals, 1975\u20131976: estimated frequency by selected characteristics of patients","volume":"70","author":"Haley","year":"1981","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.biomaterials.2005.11.031_bib94","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1163\/156856203322381447","article-title":"Gentamicin-releasing urethral catheter for short-term catheterization","volume":"14","author":"Cho","year":"2003","journal-title":"J Biomater Sci Polym Ed"},{"issue":"9","key":"10.1016\/j.biomaterials.2005.11.031_bib95","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1086\/323130","article-title":"Device-associated infections: a macroproblem that starts with microadherence","volume":"33","author":"Darouiche","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib96","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1464-410X.1997.32518.x","article-title":"Immersion in antibiotic solution prevents bacterial adhesion onto biodegradable prostatic stents","volume":"79","author":"Cormio","year":"1997","journal-title":"Br J Urol"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib97","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000049799","article-title":"Bacterial adhesion to urethral catheters: role of coating materials and immersion in antibiotic solution","volume":"40","author":"Cormio","year":"2001","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib98","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/13543776.15.2.125","article-title":"Silver and its application as an antimicrobial agent","volume":"15","author":"Melaiye","year":"2005","journal-title":"Expert Opin Therap Patents"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib99","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0002-9343(98)00240-X","article-title":"The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis","volume":"105","author":"Saint","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib100","first-page":"1","article-title":"Catheter induced urethral inflammatory reaction and urinary tract infection. An experimental and clinical study","volume":"124","author":"Liedberg","year":"1989","journal-title":"Scand J Urol Nephrol Suppl"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib101","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0022-5347(05)60356-4","article-title":"Types of urethral catheters for management of short-term voiding problems in hospitalised adults","volume":"173","author":"Brosnahan","year":"2005","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib102","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s002840010105","article-title":"Effects of hydrogel\/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections","volume":"41","author":"Ahearn","year":"2000","journal-title":"Curr Microbiol"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib103","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3201\/eid0702.010240","article-title":"Engineering out the risk for infection with urinary catheters","volume":"7","author":"Maki","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib104","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0090-4295(99)00318-0","article-title":"Hydrogel\/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study","volume":"54","author":"Bologna","year":"1999","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000068005","article-title":"Clinical application of the Bardex IC Foley catheter","volume":"36","author":"Verleyen","year":"1999","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib106","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0090-4295(99)00288-5","article-title":"Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial","volume":"54","author":"Darouiche","year":"1999","journal-title":"Urology"},{"issue":"2\u20133","key":"10.1016\/j.biomaterials.2005.11.031_bib107","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0168-6445(03)00047-0","article-title":"Bacterial silver resistance: molecular biology and uses and misuses of silver compounds","volume":"27","author":"Silver","year":"2003","journal-title":"FEMS Microbiol Rev"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib108","first-page":"449","article-title":"Development and characterization of an infection inhibiting urinary catheter","volume":"49","author":"Richards","year":"2003","journal-title":"ASAIO J"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib109","first-page":"152","article-title":"Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters","volume":"88","author":"Al-Habdan","year":"2003","journal-title":"Int Surg"},{"issue":"18","key":"10.1016\/j.biomaterials.2005.11.031_bib110","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/S0142-9612(00)00443-9","article-title":"Titanium metals form direct bonding to bone after alkali and heat treatments","volume":"22","author":"Nishiguchi","year":"2001","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib111","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ocl.2004.06.007","article-title":"Biologic fixation and bone ingrowth","volume":"36","author":"Sporer","year":"2005","journal-title":"Orthop Clin North Am"},{"issue":"420","key":"10.1016\/j.biomaterials.2005.11.031_bib112","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00003086-200403000-00003","article-title":"Mechanisms of failure of total hip replacements: lessons learned from retrieval studies","author":"Hirakawa","year":"2004","journal-title":"Clin Orthop"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib113","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/145749690309200202","article-title":"Failures and successes in total hip replacement\u2014why good ideas may not work","volume":"92","author":"Morscher","year":"2003","journal-title":"Scand J Surg"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib114","series-title":"Musculoskeletal conditions in the United States","author":"Praemer","year":"1992"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib115","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/jcb.10435","article-title":"Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation","volume":"88","author":"Gerstenfeld","year":"2003","journal-title":"J Cell Biochem"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib116","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jamcollsurg.2004.09.046","article-title":"Update on bone morphogenetic proteins and their application in spine surgery","volume":"200","author":"Samartzis","year":"2005","journal-title":"J Am Coll Surg"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib117","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejpb.2004.03.004","article-title":"Localized delivery of growth factors for bone repair","volume":"58","author":"Luginbuehl","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"issue":"7","key":"10.1016\/j.biomaterials.2005.11.031_bib118","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1517\/14712598.4.7.1015","article-title":"Bone engineering by controlled delivery of osteoinductive molecules and cells","volume":"4","author":"Leach","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"1, Suppl.","key":"10.1016\/j.biomaterials.2005.11.031_bib119","first-page":"40","article-title":"Bone morphogenetic protein-2 application by a poly(d,l-lactide)-coated interbody cage: in vivo results of a new carrier for growth factors","volume":"97","author":"Kandziora","year":"2002","journal-title":"J Neurosurg"},{"issue":"16 Suppl. 1","key":"10.1016\/j.biomaterials.2005.11.031_bib120","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/00007632-200208151-00005","article-title":"Bone morphogenetic protein delivery systems","volume":"27","author":"Seeherman","year":"2002","journal-title":"Spine"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib121","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2106\/00004623-200206000-00023","article-title":"Gene therapy in orthopaedic surgery","volume":"84","author":"Hannallah","year":"2002","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib122","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/(SICI)1097-4636(19990615)45:4<414::AID-JBM17>3.0.CO;2-Z","article-title":"Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats","volume":"45","author":"Winn","year":"1999","journal-title":"J Biomed Mater Res"},{"issue":"17","key":"10.1016\/j.biomaterials.2005.11.031_bib123","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1016\/j.biomaterials.2004.09.035","article-title":"A comparative study of biphasic calcium phosphate ceramics for human mesenchymal stem-cell-induced bone formation","volume":"26","author":"Arinzeh","year":"2005","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2005.11.031_bib124","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/79449","article-title":"Tissue-engineered bone regeneration","volume":"18","author":"Petite","year":"2000","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib125","first-page":"1","article-title":"Tissue engineering strategies for bone regeneration","volume":"94","author":"Mistry","year":"2005","journal-title":"Adv Biochem Eng Biotechnol"},{"issue":"12","key":"10.1016\/j.biomaterials.2005.11.031_bib126","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1128\/AAC.40.12.2675","article-title":"Antibiotic-impregnated cement and beads for orthopedic infections","volume":"40","author":"Winnger","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2005.11.031_bib127","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5173(00)00520-2","article-title":"Validation and in vitro characterization of antibiotic-loaded bone cement release","volume":"209","author":"Frutos","year":"2000","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib128","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0168-3659(02)00179-7","article-title":"In vitro\u2013in vivo characterization of gentamicin bone implants","volume":"83","author":"Baro","year":"2002","journal-title":"J Controlled Release"},{"issue":"8","key":"10.1016\/j.biomaterials.2005.11.031_bib129","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2106\/00004623-198668080-00026","article-title":"Antibiotic-impregnated cement in total joint arthroplasty","volume":"68","author":"Trippel","year":"1986","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/02652040010019479","article-title":"Microencapsulation of gentamicin in biodegradable PLA and\/or PLA\/PEG copolymer","volume":"18","author":"Huang","year":"2001","journal-title":"J Microencapsul"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib131","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jps.2600810611","article-title":"Self-setting hydroxyapatite cement: a novel skeletal drug delivery system for antibiotics","volume":"81","author":"Yu","year":"1992","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib132","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1243\/0954411981533881","article-title":"Bioactive bone cements","volume":"212","author":"Harper","year":"1998","journal-title":"Proc Inst Mech Eng [H]"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib133","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1473-3099(01)00094-9","article-title":"Systematic review and meta-analysis of antibiotic therapy for bone and joint infections","volume":"1","author":"Stengel","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib134","series-title":"Handbook of bacterial adhesion","first-page":"599","article-title":"Studying bacterial adhesion to antibiotic impregnated polymethyl methacrylate","author":"Edmiston","year":"2000"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib135","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2165\/00003495-200059060-00003","article-title":"Carrier systems for the local delivery of antibiotics in bone infections","volume":"59","author":"Kanellakopoulou","year":"2000","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib136","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0267-6605(91)90063-L","article-title":"Methods for improving drug release from poly(methyl methacrylate) bone cement","volume":"7","author":"Downes","year":"1991","journal-title":"Clin Mater"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib137","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0142-9612(02)00254-5","article-title":"Gentamicin release from modified acrylic bone cements with lactose and hydroxypropylmethylcellulose","volume":"24","author":"Virto","year":"2002","journal-title":"Biomaterials"},{"issue":"19","key":"10.1016\/j.biomaterials.2005.11.031_bib138","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0142-9612(00)00082-X","article-title":"Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release","volume":"21","author":"van de Belt","year":"2000","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib139","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1302\/0301-620X.59B3.408356","article-title":"Antibacterial activity of antibiotics in acrylic bone cement","volume":"59-B","author":"Picknell","year":"1977","journal-title":"J Bone Joint Surg Br"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib140","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0883-5403(05)80145-7","article-title":"Effect of varying surface patterns on antibiotic elution from antibiotic-loaded bone cement","volume":"10","author":"Masri","year":"1995","journal-title":"J Arthroplasty"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib141","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1302\/0301-620X.59B4.925056","article-title":"Bacterial infection and acrylic cement in the rat","volume":"59-B","author":"Elson","year":"1977","journal-title":"J Bone Joint Surg Br"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib142","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/1097-4636(20001215)52:4<709::AID-JBM16>3.0.CO;2-W","article-title":"Prevention of infection with tobramycin-containing bone cement or systemic cefazolin in an animal model","volume":"52","author":"Nijhof","year":"2000","journal-title":"J Biomed Mater Res"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib143","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jbm.1073","article-title":"Tobramycin-containing bone cement and systemic cefazolin in a one-stage revision. Treatment of infection in a rabbit model","volume":"58","author":"Nijhof","year":"2001","journal-title":"J Biomed Mater Res"},{"issue":"253","key":"10.1016\/j.biomaterials.2005.11.031_bib144","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00003086-199004000-00023","article-title":"Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. A five-year survey of 1688 hips","author":"Josefsson","year":"1990","journal-title":"Clin Orthop"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib145","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2106\/00004623-200205000-00009","article-title":"Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees","volume":"84-A","author":"Chiu","year":"2002","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib146","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jbm.b.10515","article-title":"Antibiotic bone cement for the treatment of Pseudomonas aeruginosa in joint arthroplasty: comparison of tobramycin and gentamicin-loaded cements","volume":"64B","author":"Scott","year":"2003","journal-title":"J Biomed Mater Res B: Appl Biomater"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib147","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1302\/0301-620X.81B3.0810440","article-title":"Effectiveness of bone cement containing tobramycin. An in vitro susceptibility study of 99 organisms found in infected joint arthroplasty","volume":"81","author":"Scott","year":"1999","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib148","series-title":"The extra pharmacopoeia: incorporating squire's \u201cCompanion\u201d","author":"Wade","year":"1977"},{"issue":"284","key":"10.1016\/j.biomaterials.2005.11.031_bib149","first-page":"303","article-title":"In vitro elution characteristics of commercially and noncommercially prepared antibiotic PMMA beads","author":"Nelson","year":"1992","journal-title":"Clin Orthop"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib150","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1302\/0301-620X.85B5.13746","article-title":"The pharmacokinetics of Simplex-tobramycin bone cement","volume":"85","author":"Sterling","year":"2003","journal-title":"J Bone Joint Surg Br"},{"issue":"190","key":"10.1016\/j.biomaterials.2005.11.031_bib151","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00003086-198411000-00014","article-title":"Antibiotic-loaded acrylic cement: current concepts","author":"Buchholz","year":"1984","journal-title":"Clin Orthop"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib152","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2106\/00004623-197658030-00011","article-title":"Antibiotic-impregnated acrylic bone cement","volume":"58","author":"Marks","year":"1976","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib153","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/17453679708996270","article-title":"Chronic osteomyelitis","volume":"68","author":"Walenkamp","year":"1997","journal-title":"Acta Orthop Scand"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib154","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0883-5403(05)80148-2","article-title":"Use of antibiotic-impregnated cement during hip and knee arthroplasty in the United States","volume":"10","author":"Heck","year":"1995","journal-title":"J Arthroplasty"},{"issue":"10","key":"10.1016\/j.biomaterials.2005.11.031_bib155","first-page":"2469","article-title":"Antibiotic-impregnated cement use in US hospitals","volume":"49","author":"Fish","year":"1992","journal-title":"Am J Hosp Pharm"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib156","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1302\/0301-620X.60B2.659478","article-title":"The release of gentamicin from polymethylmethacrylate beads. An experimental and pharmacokinetic study","volume":"60-B","author":"Wahlig","year":"1978","journal-title":"J Bone Joint Surg Br"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib157","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2106\/00004623-198163050-00015","article-title":"The depot administration of penicillin G and gentamicin in acrylic bone cement","volume":"63-A","author":"Hoff","year":"1981","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib158","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00003088-198917040-00006","article-title":"Release of gentamicin from acrylic bone cement","volume":"17","author":"Bunetel","year":"1989","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib159","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jac\/47.6.885","article-title":"Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopedic revision surgery","volume":"47","author":"Neut","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib160","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/jac\/dkg258","article-title":"Release of antimicrobial peptide Dhvar-5 from polymethyl methacrylate beads","volume":"51","author":"Faber","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib161","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1097-4636(199622)33:2<83::AID-JBM4>3.0.CO;2-H","article-title":"Calorimetric characterization of the formation of acrylic type bone cements","volume":"33","author":"Yang","year":"1996","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib162","series-title":"Bone engineering","first-page":"332","article-title":"Biological mechanisms of calcium sulfate replacement by bone","author":"Ricci","year":"2000"},{"issue":"7","key":"10.1016\/j.biomaterials.2005.11.031_bib163","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1151-2916.1991.tb07132.x","article-title":"Bioceramics: from concept to clinic","volume":"74","author":"Hench","year":"1991","journal-title":"J Am Ceram Soc"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib164","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1525-1594.1998.06004.x","article-title":"The controlled release of antibiotic by hydroxyapatite-anionic collagen composites","volume":"22","author":"Martins","year":"1998","journal-title":"Artif Organs"},{"issue":"12","key":"10.1016\/j.biomaterials.2005.11.031_bib165","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600521210","article-title":"Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices","volume":"52","author":"Higuchi","year":"1963","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib166","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0142-9612(96)00173-1","article-title":"In vivo study of a calcium phosphate cement consisting of a-tricalcium phosphate\/dicalcium phosphate dibasic\/tetracalcium phosphate monoxide","volume":"18","author":"Kurashina","year":"1997","journal-title":"Biomaterials"},{"issue":"15","key":"10.1016\/j.biomaterials.2005.11.031_bib167","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0142-9612(95)93583-Y","article-title":"Microscopic evaluation of bone-implant contact between hydroxyapatite, bioactive glass and tricalcium phosphate implanted in sheep kiaphyseal defects","volume":"16","author":"Gao","year":"1995","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib168","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00058716","article-title":"Evaluation of hydroxyapatite powder coated with collagen as an injectable bone substitute: microscopic study in rabbit","volume":"7","author":"Flautre","year":"1996","journal-title":"J Mater Sci Mater Med"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib169","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0142-9612(96)89657-8","article-title":"Biodegradable bone cement compositions based on acrylate and epoxide terminated poly(propylene fumarate) oligomers and calcium salt compositions","volume":"17","author":"Domb","year":"1996","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.biomaterials.2005.11.031_bib170","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/jbm.820271108","article-title":"Mechanisms of polymer degradation in implantable devices. 2. Poly(dl-lactic acid)","volume":"27","author":"Ali","year":"1993","journal-title":"J Biomed Mater Res"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib171","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/17453679508995563","article-title":"In vitro elution of ofloxacin from a bioabsorbable polymer","volume":"66","author":"Nie","year":"1995","journal-title":"Acta Orthop Scand"},{"issue":"362","key":"10.1016\/j.biomaterials.2005.11.031_bib172","first-page":"240","article-title":"Development of a biodegradable antibiotic delivery system","author":"Lin","year":"1999","journal-title":"Clin Orthop"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib173","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/(SICI)1097-4636(1999)48:5<613::AID-JBM4>3.0.CO;2-#","article-title":"In vitro elution of vancomycin from biodegradable beads","volume":"48","author":"Liu","year":"1999","journal-title":"J Biomed Mater Res"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib174","first-page":"212","article-title":"Polymers as a platform for drug delivery: reviewing our current portfolio on poly(lactide-co-glycolide) (PLGA) microspheres","volume":"55","author":"Gander","year":"2001","journal-title":"Chimica"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Anderson","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib176","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.0.CO;2-X","article-title":"Biodegradable polyesters for medical and ecological applications","volume":"21","author":"Ikada","year":"2000","journal-title":"Macromol Rapid Commun"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib177","unstructured":"Huh KM, Cho YW, Park K. PLGA\u2013PEG block copolymers for drug formulations. Drug Deliv Technol 2003; 3 (5): 42, 44\u20139."},{"issue":"27","key":"10.1016\/j.biomaterials.2005.11.031_bib178","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/S0142-9612(03)00413-7","article-title":"Chitin\/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein","volume":"24","author":"Mi","year":"2003","journal-title":"Biomaterials"},{"issue":"18","key":"10.1016\/j.biomaterials.2005.11.031_bib179","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1016\/j.biomaterials.2004.10.004","article-title":"Short term in vivo biocompatibility testing of biodegradable poly(d,l-lactide)-growth factor coating for orthopedic implants","volume":"26","author":"Wildemann","year":"2005","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2005.11.031_bib180","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2106\/00004623-199809000-00013","article-title":"Anti-infective efficacy of antiseptic-coated intramedullary nails","volume":"80","author":"Darouiche","year":"1998","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib181","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0169-409X(95)00092-L","article-title":"Biosynthetic polyhydroxyalkanoates and their potential in drug delivery","volume":"18","author":"Pouton","year":"1996","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"10.1016\/j.biomaterials.2005.11.031_bib182","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0167-7799(96)10061-5","article-title":"Plastic bacteria? Progress and prospects for polyhydroxyalkanoate production in bacteria","volume":"14","author":"Lee","year":"1996","journal-title":"Trends Biotechnol"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib183","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0142-9612(00)00170-8","article-title":"In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis","volume":"22","author":"Gursel","year":"2001","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib184","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/bit.20168","article-title":"Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices","volume":"89","author":"Schmoekel","year":"2004","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib185","series-title":"Principles of tissue engineering","first-page":"129","article-title":"Growth factors","author":"Deuel","year":"2000"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib186","series-title":"The adult knee","first-page":"289","article-title":"Fixation of implants","author":"Sumner","year":"2003"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib187","series-title":"Orthopaedic basic science, anonymous","first-page":"401","article-title":"Biological response to orthopaedic implants","author":"Jacobs","year":"2000"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib188","series-title":"Joint replacements and bone resorption: pathology, biomaterials and clinical practice","article-title":"Fixation of implants","author":"Moucha","year":"2005"},{"issue":"1\u20133","key":"10.1016\/j.biomaterials.2005.11.031_bib189","first-page":"47","article-title":"Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy","volume":"11","author":"Richardson","year":"2001","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/10611860108998775","article-title":"Promoting angiogenesis in engineered tissues","volume":"9","author":"Bouhadir","year":"2001","journal-title":"J Drug Target"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib191","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.mn.7800120","article-title":"Nonviral gene transfer strategies for the vasculature","volume":"9","author":"Young","year":"2002","journal-title":"Microcirculation"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib192","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1046\/j.1460-9568.2003.02830.x","article-title":"An antagonist of estrogen receptors blocks the induction of adult neurogenesis by insulin-like growth factor-I in the dentate gyrus of adult female rat","volume":"18","author":"Perez-Martin","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib193","series-title":"Principles of tissue engineering","author":"Lanza","year":"2000"},{"issue":"1","key":"10.1016\/j.biomaterials.2005.11.031_bib194","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00129334-200501000-00017","article-title":"The art of skin and wound care documentation","volume":"18","author":"Hess","year":"2003","journal-title":"Adv Skin Wound Care"},{"issue":"3\u20134","key":"10.1016\/j.biomaterials.2005.11.031_bib195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF01420065","article-title":"In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections","volume":"133","author":"Hampl","year":"1995","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib196","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jab.770020309","article-title":"Implants for site-specific drug delivery","volume":"2","author":"Labhasetwar","year":"1991","journal-title":"Journal of Applied Biomaterials: An Official Journal of the Society for Biomaterials"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib197","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1540-8159.1988.tb04543.x","article-title":"The porous titanium steroid eluting electrode: a double blind study assessing the stimulation threshold effects of steroid","volume":"11","author":"Mond","year":"1988","journal-title":"Pacing Clin Electrophysiol"},{"issue":"12 Pt 2","key":"10.1016\/j.biomaterials.2005.11.031_bib198","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/j.1540-8159.1990.tb06910.x","article-title":"Steroid-tipped leads versus porous platinum permanent pacemaker leads: a controlled study","volume":"13","author":"Wish","year":"1990","journal-title":"Pacing Clin Electrophysiol"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib199","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1540-8159.2005.40055.x","article-title":"A comparative study of the action of dexamethasone sodium phosphate and dexamethasone acetate in steroid-eluting pacemaker leads","volume":"28","author":"Singarayar","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib200","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1089\/dia.2004.6.887","article-title":"Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres\/poly(vinyl alcohol) hydrogel composite coatings for inflammation control","volume":"6","author":"Patil","year":"2004","journal-title":"Diabetes Technol Therap"},{"issue":"2","key":"10.1016\/j.biomaterials.2005.11.031_bib201","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jbm.10016","article-title":"In vivo evaluation of a dexamethasone\/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices","volume":"61","author":"Hickey","year":"2002","journal-title":"J Biomed Mater Res"},{"issue":"6","key":"10.1016\/j.biomaterials.2005.11.031_bib202","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00002480-199911000-00009","article-title":"Assessment of chronically implanted subcutaneous glucose sensors in dogs: the effect of surrounding fluid masses","volume":"45","author":"Ward","year":"1999","journal-title":"ASAIO J"},{"issue":"12","key":"10.1016\/j.biomaterials.2005.11.031_bib203","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0142-9612(00)00003-X","article-title":"Synthesis and characterization of a novel biodegradable antimicrobial polymer","volume":"21","author":"Woo","year":"2000","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.biomaterials.2005.11.031_bib204","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jbm.a.30184","article-title":"Salicylic acid-derived poly(anhydride-esters) inhibit bone resorption and formation in vivo","volume":"72A","author":"Harten","year":"2005","journal-title":"J Biomed Mater Res A"},{"issue":"5","key":"10.1016\/j.biomaterials.2005.11.031_bib205","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1021\/js980418j","article-title":"A novel microbial infection-responsive drug release system","volume":"88","author":"Tanihara","year":"1999","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.biomaterials.2005.11.031_bib206","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0196-9781(97)00420-8","article-title":"Thrombin-sensitive peptide linkers for biological signal-responsive drug release systems","volume":"19","author":"Tanihara","year":"1998","journal-title":"Peptides (New York)"},{"issue":"7","key":"10.1016\/j.biomaterials.2005.11.031_bib207","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1517\/14712598.4.7.1029","article-title":"Controlled-release and local delivery of therapeutic antibodies","volume":"4","author":"Grainger","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib208","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/1521-3900(200107)172:1<35::AID-MASY35>3.0.CO;2-N","article-title":"Mechanisms of anticancer action of HPMA copolymer-bound doxorubicin","volume":"172","author":"Minko","year":"2001","journal-title":"Macromol Symp"},{"key":"10.1016\/j.biomaterials.2005.11.031_bib209","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1749-6632.2002.tb03056.x","article-title":"Emerging design principles in biomaterials and scaffolds for tissue engineering","volume":"961","author":"Griffith","year":"2002","journal-title":"Ann N Y Acad Sci"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961205010574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961205010574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T14:50:40Z","timestamp":1758898240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961205010574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":209,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0142961205010574"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2005.11.031","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug\/device combinations for local drug therapies and infection prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2005.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}